Molecular Imaging: Page 474

FDG-PET predicts response, survival in postchemo breast cancer patients

By Shalmali Pal

While the survival rates for neoadjuvant therapy are on par with those of adjuvant treatment, the same can't be said for high-dose chemotherapy regimens. Two published papers from the U.K. and Australia looked for ways to single out responders to treatment. The first used FDG-PET to predict breast cancer's pathologic response to therapy, while the second used the modality for prognostic stratification after high-dose chemotherapy.

October 29, 2006

Study: Global molecular therapies market tops $7 billion

By AuntMinnie.com staff writers

The worldwide molecular-targeted therapies (MTT) market reached $7.5 billion in 2005.

October 26, 2006

Study backs dual modality of microSPECT/CT

By AuntMinnie.com staff writers

Mayo Clinic researchers say the combined technologies of microSPECT and microCT imaging can accurately quantify intratumoral radioisotope uptake in vivo, and the hybrid technique is more reliable than planar or microSPECT imaging alone.

October 25, 2006

Scintigraphy pegs potential responders to plantar fasciitis treatment

By Shalmali Pal

Plantar fasciitis is the most common cause of heel pain but the differential diagnosis can include Achilles tendinitis, retrocalcaneal bursitis, and calcaneum fracture. Bone scintigraphy is often used to identify the source of heel pain, and the modality may play a predictive role in treatment as well, according to a new study by researchers from Australia and the U.K.

October 24, 2006

Unger steps down at ImaRx

Biopharmaceutical company ImaRx Therapeutics of Tucson, AZ, is reporting that Dr. Evan Unger is stepping down from his positions as president and CEO of the company.

October 23, 2006

Schaumburg promoted to top post at UltraSPECT

Nuclear medicine firm UltraSPECT has promoted John Schaumburg to the post of president.

October 23, 2006

Instrumentation, attenuation correction steer nuclear cardiology's future

By Eric Barnes

Nuclear cardiology modalities are seeing a resurgence of late, which is not to say the most widespread heart-imaging modalities were in decline. Still, recent technical improvements on multiple fronts, from detector technology to hybrid modalities like SPECT/CT and PET/CT, seem to have sharpened the modalities' future prospects as they have sharpened the images themselves.

October 22, 2006

Tips for successful pediatric nuclear imaging

The prospect of scanning a pediatric patient can create fear and self-doubt in even the most experienced technologist. Yet most techs will encounter children as patients at some time and with some frequency. Nuclear medicine technologist Sandy Ferency of SPECT imaging provider Brain Matters in Denver shares some important tips to help achieve a good quality scan and a happy patient.

October 19, 2006

Capintec, Numa collaborate

By AuntMinnie.com staff writers

Nuclear medicine connectivity firm Numa has signed a development agreement with radiation measurement device developer Capintec of Ramsey, NJ.

October 16, 2006

IsoRay reaches seed century mark

By AuntMinnie.com staff writers

Medical isotope developer IsoRay reported that the Chicago Prostate Cancer Center (CPCC) of Westmont, IL, reached a milestone in prostate brachytherapy earlier this month by becoming the first cancer center to treat 100 patients using the company's cesium-131 seeds.

October 16, 2006

DRA threatens to throttle PET

By Jonathan S. Batchelor

PET and PET/CT proponents in the U.S. have fought long and hard to get their modalities included in the nonacademic diagnostic armamentarium. But their victories could be critically imperiled if reimbursement cuts mandated in the Deficit Reduction Act (DRA) of 2005 are implemented as scheduled in less than three months.

October 12, 2006

Societies lay plans for NM physician extenders

By AuntMinnie.com staff writers

The American Registry of Radiologic Technologists and the Nuclear Medicine Technology Certification Board this week said they were working together to create a new class of advanced nuclear medicine technologists, to be called nuclear medicine practitioners (NMPs).

October 11, 2006

Previous Page

Page 474 of 611

Next Page